BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19191727)

  • 1. Age and hormone replacement therapy as factors influencing androgen levels in the postmenopausal female.
    Ali I; James T; Meston N; Wojnarowska F; Shine B
    Clin Chem Lab Med; 2009; 47(2):202-7. PubMed ID: 19191727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women.
    Stomati M; Hartmann B; Spinetti A; Mailand D; Rubino S; Albrecht A; Huber J; Petraglia F; Genazzani AR
    J Endocrinol Invest; 1996 Sep; 19(8):535-41. PubMed ID: 8905477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
    Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
    Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin.
    Kraemer GR; Kraemer RR; Ogden BW; Kilpatrick RE; Gimpel TL; Castracane VD
    Fertil Steril; 2003 Mar; 79(3):534-42. PubMed ID: 12620436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen and SHBG serum concentrations in late post-menopause women.
    Skałba P; Wójtowicz M; Sikora J
    Med Sci Monit; 2003 Mar; 9(3):CR152-6. PubMed ID: 12640346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status.
    Gravholt CH; Svenstrup B; Bennett P; Sandahl Christiansen J
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):791-800. PubMed ID: 10468952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen levels in adult females: changes with age, menopause, and oophorectomy.
    Davison SL; Bell R; Donath S; Montalto JG; Davis SR
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3847-53. PubMed ID: 15827095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
    Kaaks R; Rinaldi S; Key TJ; Berrino F; Peeters PH; Biessy C; Dossus L; Lukanova A; Bingham S; Khaw KT; Allen NE; Bueno-de-Mesquita HB; van Gils CH; Grobbee D; Boeing H; Lahmann PH; Nagel G; Chang-Claude J; Clavel-Chapelon F; Fournier A; Thiébaut A; González CA; Quirós JR; Tormo MJ; Ardanaz E; Amiano P; Krogh V; Palli D; Panico S; Tumino R; Vineis P; Trichopoulou A; Kalapothaki V; Trichopoulos D; Ferrari P; Norat T; Saracci R; Riboli E
    Endocr Relat Cancer; 2005 Dec; 12(4):1071-82. PubMed ID: 16322344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition.
    Burger HG; Dudley EC; Cui J; Dennerstein L; Hopper JL
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2832-8. PubMed ID: 10946891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women.
    Lukanova A; Lundin E; Zeleniuch-Jacquotte A; Muti P; Mure A; Rinaldi S; Dossus L; Micheli A; Arslan A; Lenner P; Shore RE; Krogh V; Koenig KL; Riboli E; Berrino F; Hallmans G; Stattin P; Toniolo P; Kaaks R
    Eur J Endocrinol; 2004 Feb; 150(2):161-71. PubMed ID: 14763914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism.
    Isidori AM; Kaltsas GA; Perry L; Burrin JM; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2003 May; 58(5):601-11. PubMed ID: 12699442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex steroids, sex hormone-binding globulin and levels of N-terminal pro-brain natriuretic peptide in postmenopausal women.
    Glisic M; Rojas LZ; Asllanaj E; Vargas KG; Kavousi M; Ikram MA; Fauser BCJM; Laven JSE; Muka T; Franco OH
    Int J Cardiol; 2018 Jun; 261():189-195. PubMed ID: 29551255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
    Vermeulen A; Kaufman JM; Giagulli VA
    J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on relationship between endogenous androgens and insulin resistance at the different stages of postmenopause].
    Cao YK; Zhang SF; Zou SE; Xia X; Xu LN
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):740-4. PubMed ID: 24406129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
    Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
    J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgens in relationship to cardiovascular risk factors in the menopausal transition.
    Mesch VR; Siseles NO; Maidana PN; Boero LE; Sayegh F; Prada M; Royer M; Schreier L; Benencia HJ; Berg GA
    Climacteric; 2008; 11(6):509-17. PubMed ID: 18991078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does androgen excess contribute to the cardiovascular risk profile in postmenopausal women with type 2 diabetes?
    Korytkowski MT; Krug EI; Daly MA; Deriso L; Wilson JW; Winters SJ
    Metabolism; 2005 Dec; 54(12):1626-31. PubMed ID: 16311096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.